The Role of Peroxisome Proliferator-Activated Receptors in Polycystic Ovary Syndrome
Journal of Clinical Medicine · 17.04.2023 · 12 (8) · 2912
DOI: 10.3390/jcm12082912 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 17.04.2023. Verfasst von Iason Psilopatis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, August…. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Polycystic ovary syndrome (PCOS) constitutes the most common endocrine disorder in women of reproductive age. Patients usually suffer from severe menstrual irregularities, skin conditions, and insulin resistance-associated health conditions. Peroxisome proliferator-activated receptors (PPARs) are nuclear receptor proteins that regulate gene expression. In order to investigate the role of PPARs in the pathophysiology of PCOS, we conducted a literature review using the MEDLINE and LIVIVO databases and were able to identify 74 relevant studies published between 2003 and 2023. Different study groups reached contradictory conclusions in terms of PPAR expression in PCOS. Interestingly, numerous natural agents were found to represent a novel, potent anti-PCOS treatment alternatives. In conclusion, PPARs seem to play a significant role in PCOS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
- First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, Bld 10, Goudi, 11527 Athens, Greece.
ORCID-Profile: Iason Psilopatis, Kostas Palamaris
Zitieren
APA
Psilopatis, I., Vrettou, K., Nousiopoulou, E., Palamaris, K., & Theocharis, S. (2023). The Role of Peroxisome Proliferator-Activated Receptors in Polycystic Ovary Syndrome. Journal of Clinical Medicine, 12(8), 2912. https://doi.org/10.3390/jcm12082912
Vancouver
Psilopatis I, Vrettou K, Nousiopoulou E, Palamaris K, Theocharis S. The Role of Peroxisome Proliferator-Activated Receptors in Polycystic Ovary Syndrome. Journal of Clinical Medicine. 2023;12(8):2912. doi:10.3390/jcm12082912
BibTeX
@article{Psilopatis2023,
author = {Psilopatis, Iason and Vrettou, Kleio and Nousiopoulou, Eleni and Palamaris, Kostas and Theocharis, Stamatios},
title = {The Role of Peroxisome Proliferator-Activated Receptors in Polycystic Ovary Syndrome},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {8},
pages = {2912},
doi = {10.3390/jcm12082912}
}
EUVIMED